| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 11 | 2025 | 520 | 4.130 |
Why?
|
| Hematopoietic Stem Cells | 18 | 2024 | 538 | 3.860 |
Why?
|
| Neoplastic Stem Cells | 5 | 2025 | 321 | 2.010 |
Why?
|
| Cell Cycle Proteins | 10 | 2021 | 664 | 1.750 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2025 | 559 | 1.520 |
Why?
|
| AMP-Activated Protein Kinases | 5 | 2020 | 162 | 1.360 |
Why?
|
| Adult Stem Cells | 2 | 2021 | 54 | 1.270 |
Why?
|
| Transcription Factors | 6 | 2025 | 2603 | 1.270 |
Why?
|
| Leukemia | 6 | 2021 | 367 | 1.150 |
Why?
|
| Hematopoiesis | 5 | 2022 | 215 | 1.130 |
Why?
|
| Erythroid Cells | 2 | 2024 | 24 | 0.950 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2025 | 66 | 0.910 |
Why?
|
| Homeostasis | 4 | 2021 | 704 | 0.900 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2025 | 161 | 0.860 |
Why?
|
| Dioxygenases | 1 | 2024 | 46 | 0.850 |
Why?
|
| Estrogens | 2 | 2018 | 504 | 0.840 |
Why?
|
| Cell Differentiation | 5 | 2024 | 1908 | 0.840 |
Why?
|
| Polycomb Repressive Complex 1 | 4 | 2022 | 34 | 0.830 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2021 | 13 | 0.740 |
Why?
|
| Histone Chaperones | 1 | 2021 | 12 | 0.740 |
Why?
|
| CRISPR-Cas Systems | 3 | 2018 | 256 | 0.720 |
Why?
|
| Saccharomyces cerevisiae Proteins | 6 | 2005 | 280 | 0.720 |
Why?
|
| Mice | 23 | 2025 | 17743 | 0.690 |
Why?
|
| DNA-Binding Proteins | 7 | 2024 | 2061 | 0.690 |
Why?
|
| Acetyl Coenzyme A | 1 | 2019 | 13 | 0.660 |
Why?
|
| Animals | 31 | 2025 | 34309 | 0.660 |
Why?
|
| Anemia | 1 | 2024 | 341 | 0.660 |
Why?
|
| Gene Editing | 3 | 2018 | 186 | 0.650 |
Why?
|
| Megakaryocyte-Erythroid Progenitor Cells | 1 | 2019 | 3 | 0.650 |
Why?
|
| Saccharomyces cerevisiae | 6 | 2005 | 429 | 0.630 |
Why?
|
| Azacitidine | 1 | 2019 | 54 | 0.610 |
Why?
|
| Adipocytes | 1 | 2019 | 141 | 0.600 |
Why?
|
| DNA Damage | 7 | 2019 | 516 | 0.590 |
Why?
|
| Polycomb-Group Proteins | 1 | 2018 | 19 | 0.590 |
Why?
|
| Clone Cells | 1 | 2018 | 168 | 0.570 |
Why?
|
| Cell Cycle | 5 | 2012 | 627 | 0.570 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 62 | 0.570 |
Why?
|
| Endoribonucleases | 1 | 2018 | 83 | 0.550 |
Why?
|
| Carcinogenesis | 3 | 2022 | 340 | 0.540 |
Why?
|
| Estrogen Receptor alpha | 2 | 2018 | 458 | 0.530 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 634 | 0.520 |
Why?
|
| Stem Cells | 4 | 2019 | 709 | 0.520 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 4420 | 0.520 |
Why?
|
| Fungal Proteins | 4 | 2004 | 134 | 0.500 |
Why?
|
| Bone Marrow | 1 | 2015 | 322 | 0.430 |
Why?
|
| Spleen | 3 | 2024 | 281 | 0.420 |
Why?
|
| Histones | 3 | 2021 | 542 | 0.390 |
Why?
|
| Protein Kinases | 1 | 2014 | 331 | 0.380 |
Why?
|
| Energy Metabolism | 3 | 2020 | 765 | 0.380 |
Why?
|
| Guided Tissue Regeneration | 1 | 2011 | 4 | 0.370 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2020 | 560 | 0.340 |
Why?
|
| Oxidative Stress | 1 | 2015 | 818 | 0.340 |
Why?
|
| Clonal Evolution | 2 | 2020 | 41 | 0.340 |
Why?
|
| Stem Cell Niche | 2 | 2020 | 56 | 0.330 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2019 | 63 | 0.320 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2022 | 102 | 0.300 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 2414 | 0.300 |
Why?
|
| Mutation | 8 | 2024 | 5903 | 0.300 |
Why?
|
| Signal Transduction | 10 | 2020 | 4595 | 0.290 |
Why?
|
| Phosphoproteins | 3 | 2012 | 420 | 0.280 |
Why?
|
| Phleomycins | 2 | 2004 | 6 | 0.270 |
Why?
|
| Cell Line, Tumor | 3 | 2025 | 3419 | 0.270 |
Why?
|
| DNA, Fungal | 2 | 2004 | 77 | 0.270 |
Why?
|
| Humans | 25 | 2025 | 125309 | 0.260 |
Why?
|
| IMP Dehydrogenase | 1 | 2025 | 26 | 0.240 |
Why?
|
| Checkpoint Kinase 2 | 5 | 2024 | 36 | 0.240 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2025 | 560 | 0.230 |
Why?
|
| Endodeoxyribonucleases | 1 | 2004 | 46 | 0.230 |
Why?
|
| Exodeoxyribonucleases | 1 | 2004 | 51 | 0.230 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2012 | 436 | 0.230 |
Why?
|
| Cell Self Renewal | 2 | 2021 | 45 | 0.230 |
Why?
|
| Mice, Knockout | 4 | 2021 | 3753 | 0.220 |
Why?
|
| Blood Pressure Determination | 1 | 2024 | 112 | 0.220 |
Why?
|
| Arterial Pressure | 1 | 2024 | 112 | 0.210 |
Why?
|
| Iron | 2 | 2024 | 277 | 0.210 |
Why?
|
| Phosphorylation | 7 | 2020 | 1638 | 0.200 |
Why?
|
| Selenium | 1 | 2022 | 17 | 0.190 |
Why?
|
| Proteostasis | 1 | 2022 | 34 | 0.190 |
Why?
|
| Gene Deletion | 4 | 2016 | 793 | 0.190 |
Why?
|
| Gene Ontology | 1 | 2021 | 46 | 0.180 |
Why?
|
| NAD | 1 | 2021 | 45 | 0.180 |
Why?
|
| Cell Division | 2 | 2014 | 780 | 0.180 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2020 | 31 | 0.170 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2020 | 21 | 0.170 |
Why?
|
| Multiprotein Complexes | 2 | 2012 | 210 | 0.170 |
Why?
|
| Ribonucleoproteins | 2 | 2018 | 64 | 0.170 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 4406 | 0.170 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2020 | 17 | 0.170 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2012 | 260 | 0.160 |
Why?
|
| Models, Biological | 2 | 2021 | 1465 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 733 | 0.160 |
Why?
|
| Lipid Peroxidation | 1 | 2020 | 96 | 0.160 |
Why?
|
| Cell Proliferation | 4 | 2016 | 2372 | 0.160 |
Why?
|
| Animals, Newborn | 2 | 2021 | 1018 | 0.160 |
Why?
|
| PAX3 Transcription Factor | 1 | 2019 | 28 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 217 | 0.160 |
Why?
|
| Acetylation | 1 | 2019 | 168 | 0.160 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 299 | 0.160 |
Why?
|
| Blood Platelets | 1 | 2022 | 325 | 0.160 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 114 | 0.160 |
Why?
|
| Hematologic Diseases | 1 | 2019 | 78 | 0.150 |
Why?
|
| Methylation | 1 | 2019 | 224 | 0.150 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 276 | 0.150 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2019 | 39 | 0.150 |
Why?
|
| Adipogenesis | 1 | 2019 | 72 | 0.150 |
Why?
|
| Preleukemia | 1 | 2018 | 1 | 0.150 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 52 | 0.150 |
Why?
|
| Cellular Senescence | 1 | 2019 | 163 | 0.140 |
Why?
|
| INDEL Mutation | 1 | 2018 | 88 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 359 | 0.140 |
Why?
|
| Genes, Neoplasm | 1 | 2018 | 83 | 0.140 |
Why?
|
| Environmental Exposure | 1 | 2019 | 220 | 0.140 |
Why?
|
| RNA Interference | 1 | 2019 | 508 | 0.140 |
Why?
|
| Translocation, Genetic | 1 | 2019 | 358 | 0.140 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 670 | 0.140 |
Why?
|
| Sulfonamides | 1 | 2019 | 270 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 363 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 914 | 0.130 |
Why?
|
| Cellular Microenvironment | 1 | 2016 | 8 | 0.130 |
Why?
|
| Protein Binding | 1 | 2019 | 1755 | 0.120 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 564 | 0.120 |
Why?
|
| Replication Protein A | 2 | 2005 | 11 | 0.120 |
Why?
|
| Trans-Activators | 1 | 2019 | 801 | 0.120 |
Why?
|
| Cell Survival | 2 | 2010 | 820 | 0.120 |
Why?
|
| Age Factors | 1 | 2021 | 2817 | 0.120 |
Why?
|
| Apoptosis | 1 | 2021 | 1817 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1756 | 0.110 |
Why?
|
| Prosencephalon | 1 | 2014 | 42 | 0.110 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 60 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2018 | 3043 | 0.110 |
Why?
|
| Female | 8 | 2024 | 66791 | 0.110 |
Why?
|
| Erythropoiesis | 1 | 2014 | 42 | 0.110 |
Why?
|
| Male | 7 | 2024 | 61531 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2093 | 0.110 |
Why?
|
| Cell Count | 1 | 2014 | 252 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2013 | 64 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2012 | 626 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1363 | 0.100 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 135 | 0.100 |
Why?
|
| Protein Phosphatase 2C | 2 | 2024 | 55 | 0.100 |
Why?
|
| Disease Progression | 1 | 2018 | 2083 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2014 | 314 | 0.100 |
Why?
|
| Cytosol | 1 | 2012 | 162 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1244 | 0.090 |
Why?
|
| DNA Replication | 2 | 2004 | 357 | 0.090 |
Why?
|
| Ovary | 1 | 2014 | 380 | 0.090 |
Why?
|
| Neoplasms | 2 | 2024 | 2799 | 0.090 |
Why?
|
| Centrosome | 1 | 2010 | 35 | 0.090 |
Why?
|
| Pancytopenia | 1 | 2010 | 41 | 0.090 |
Why?
|
| Spindle Apparatus | 1 | 2010 | 63 | 0.090 |
Why?
|
| Catalytic Domain | 1 | 2010 | 161 | 0.080 |
Why?
|
| Cell Death | 1 | 2010 | 240 | 0.080 |
Why?
|
| Aneuploidy | 1 | 2010 | 153 | 0.080 |
Why?
|
| Aging | 2 | 2014 | 1182 | 0.080 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2010 | 166 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2010 | 214 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 690 | 0.080 |
Why?
|
| Sirolimus | 1 | 2010 | 227 | 0.080 |
Why?
|
| Nerve Net | 1 | 2011 | 243 | 0.070 |
Why?
|
| Regeneration | 1 | 2010 | 212 | 0.070 |
Why?
|
| Aged | 3 | 2024 | 19711 | 0.070 |
Why?
|
| Integrases | 2 | 2021 | 160 | 0.070 |
Why?
|
| Mitochondria | 1 | 2010 | 679 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 65 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2024 | 746 | 0.060 |
Why?
|
| Proteins | 1 | 2010 | 1039 | 0.060 |
Why?
|
| Genes, Fungal | 1 | 2004 | 63 | 0.060 |
Why?
|
| Prone Position | 1 | 2024 | 33 | 0.060 |
Why?
|
| Genes, cdc | 1 | 2004 | 25 | 0.060 |
Why?
|
| Patient Positioning | 1 | 2024 | 55 | 0.050 |
Why?
|
| Monitoring, Intraoperative | 1 | 2024 | 133 | 0.050 |
Why?
|
| Methyl Methanesulfonate | 1 | 2003 | 2 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2003 | 13 | 0.050 |
Why?
|
| G2 Phase | 1 | 2003 | 44 | 0.050 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2003 | 100 | 0.050 |
Why?
|
| S Phase | 1 | 2003 | 75 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 1980 | 0.050 |
Why?
|
| RNA, Ribosomal | 1 | 2022 | 63 | 0.050 |
Why?
|
| Protein Aggregates | 1 | 2022 | 30 | 0.050 |
Why?
|
| Mitosis | 1 | 2003 | 241 | 0.050 |
Why?
|
| Receptor, TIE-2 | 1 | 2021 | 12 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2003 | 528 | 0.050 |
Why?
|
| Oncogenes | 1 | 2022 | 176 | 0.050 |
Why?
|
| Pregnancy | 1 | 2014 | 7225 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2013 | 339 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 472 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2021 | 92 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2021 | 184 | 0.040 |
Why?
|
| Cyclohexylamines | 1 | 2020 | 5 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2013 | 739 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2022 | 298 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 681 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 175 | 0.040 |
Why?
|
| A549 Cells | 1 | 2020 | 44 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 493 | 0.040 |
Why?
|
| Phenylenediamines | 1 | 2020 | 24 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2020 | 65 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 102 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 222 | 0.040 |
Why?
|
| Kinetics | 1 | 2021 | 1333 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2024 | 1377 | 0.040 |
Why?
|
| DNA Repair | 2 | 2016 | 591 | 0.040 |
Why?
|
| Piperazines | 1 | 2020 | 242 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2020 | 256 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 288 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 455 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 2524 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2020 | 761 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2020 | 306 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 779 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2020 | 377 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2016 | 91 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 126 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2020 | 887 | 0.030 |
Why?
|
| Glucose | 1 | 2020 | 878 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 887 | 0.030 |
Why?
|
| Antimitotic Agents | 1 | 2014 | 1 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 1763 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 385 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 216 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 158 | 0.030 |
Why?
|
| Pancreas | 1 | 2015 | 220 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2014 | 96 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 106 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 230 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 26741 | 0.030 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2012 | 6 | 0.030 |
Why?
|
| Genomics | 1 | 2020 | 1520 | 0.020 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2012 | 29 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2013 | 165 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2012 | 25 | 0.020 |
Why?
|
| Blood Cells | 1 | 2012 | 50 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 92 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 57 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2014 | 198 | 0.020 |
Why?
|
| Neuroglia | 1 | 2014 | 206 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 495 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3102 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 4828 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 767 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 691 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 802 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2012 | 578 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 2755 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1034 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 16360 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 4269 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 1097 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 2004 | 74 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 29528 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 200 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2004 | 448 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6308 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 396 | 0.010 |
Why?
|
| Replication Protein C | 1 | 2001 | 6 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 657 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2002 | 836 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 3109 | 0.010 |
Why?
|